Structural Formula (Glycerol Phenylbutyrate Oral Liquid 1)
Glycerol Phenylbutyrate Liquid
Product Images NDC 49884-264
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Glycerol Phenylbutyrate (NDC 49884-264). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Glycerol Phenylbutyrate Oral Liquid 2)
This appears to be a description of a biochemical process involving ester hydrolysis, pancreatic lipases, glutamate, phenylbutyric acid, beta oxidation, glutamine, phenylacetate, and urine excretion. The text also mentions chemicals such as glycerol phenylbutyrate, ketoglutarate, and phenylacetylglutamine.*
Figure 2 (Glycerol Phenylbutyrate Oral Liquid 3)
Figure 3 (Glycerol Phenylbutyrate Oral Liquid 4)
Figure 4 (Glycerol Phenylbutyrate Oral Liquid 5)
Figure 5 (Glycerol Phenylbutyrate Oral Liquid 6)
Container Label (Glycerol Phenylbutyrate Oral Liquid 7)
This is a medication label for Glycerol Phenylbutyrate Oral Liquid, containing 1.1 grams per mL. The recommended dosage is for inflammation, with storage instructions between 25°C to 77.8°C. Unused portions should be discarded after 28 days. It is advised to keep the medication out of reach of children. The pharmacist contact number is provided for any inquiries. The manufacturer is listed as Anaras Pharma Private Limited.*
Carton Label (Glycerol Phenylbutyrate Oral Liquid 8)
This is a description of a medication called Glycerol Phenylbutyrate Oral Liquid. Each milliliter of this liquid contains 1.1 grams of glycerol phenylbutyrate, delivering 1.02 grams of phenylbutyrate. The medication is for oral use only and the usual dosage should be followed as per prescribing information. It is advised to store the medication at 20° to 25°C (68° to 77°F), with excursions permitted to 15° to 30°C (59° to 86°F). The medication should be kept out of reach of children and should be used with a measuring device appropriate for the prescribed dose. The product should be discarded 28 days after the first opening. The medication is manufactured by Annora Pharma Private Limited in India and is manufactured for Endo USA based in Malvern, PA. Batches and expiration dates are also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
